Last Update 5:10
Sunday, 25 July 2021

Egypt detects 613 new coronavirus cases, 56 fatalities on Monday

Health Minister Hala Zayed told a WHO meeting last week that infections in the overpopulous country is set to increase by April with the curve expected to decline in May

Ahram Online , Tuesday 16 Feb 2021
Egypt
The government is warning citizens to adhere to the preventive measures (photo: Reuters)
Share/Bookmark
Share/Bookmark

Egypt detected 613 new coronavirus cases on Monday, bringing its total infections tally to 174,426 since the outbreak last year.

The health ministry reported 56 new deaths, bringing overall fatalities from the virus nationwide to 10,050.

389 patients have been discharged from hospitals over the past 24 hours to mark total recoveries at 135,349.

Despite Egypt entering the second wave of the pandemic in early December, the country witnessed a decline in the daily infection rate in January before fluctuating up and down since last week.

Zayed told a World Health Organization (WHO) meeting last week that infections in the overpopulous country is set to increase by April with the curve expected to decline in May.

Fears over a renewed spike in cases come as Egypt continues to intensify efforts to vaccinate its medical staff at hospitals nationwide.

Egypt began its vaccination process mid-January with the Chinese Sinopharm vaccine, which is administered in two doses 21 days apart, beginning with health frontliners in isolation hospitals nationwide.

It will start on Saturday the vaccine rollout for medical staff at all hospitals that are not designated for coronavirus treatment and citizens suffering from chronic diseases.

The expansion in the vaccination campaign comes after the ministry supplied the vaccine to medical staff in 363 coronavirus-designated hospitals.

Egypt received the first batch of the Chinese vaccine - 50,000 doses - in December from the UAE.

The ministry approved the vaccine in early January and is expecting a second batch soon.

On 31 January, Egypt received the first batch of the British AstraZeneca COVID-19, which consists of 50,000 doses, as part of an agreement reached between the UPA and the producer, India's R-pharma and Serum Institute.

The agreement comprises the procurement of a total of 20 million doses and the transfer of vaccine manufacturing technology to Egypt. 

Search Keywords:
Short link:

 

Latest

© 2010 Ahram Online.